These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27540464)

  • 1. β-cell replacement sources for type 1 diabetes: a focus on pancreatic ductal cells.
    Corritore E; Lee YS; Sokal EM; Lysy PA
    Ther Adv Endocrinol Metab; 2016 Aug; 7(4):182-99. PubMed ID: 27540464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can pancreatic duct-derived progenitors be a source of islet regeneration?
    Xia B; Zhan XR; Yi R; Yang B
    Biochem Biophys Res Commun; 2009 Jun; 383(4):383-5. PubMed ID: 19324022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of diabetes in rats using GLP-1-expressing adult pancreatic duct-like precursor cells transformed from acinar to ductal cells.
    Lee J; Wen J; Park JY; Kim SA; Lee EJ; Song SY
    Stem Cells Dev; 2009 Sep; 18(7):991-1002. PubMed ID: 19125629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet Neogenesis Associated Protein (INGAP) induces the differentiation of an adult human pancreatic ductal cell line into insulin-expressing cells through stepwise activation of key transcription factors for embryonic beta cell development.
    Assouline-Thomas B; Ellis D; Petropavlovskaia M; Makhlin J; Ding J; Rosenberg L
    Differentiation; 2015; 90(4-5):77-90. PubMed ID: 26558987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progenitor potential of nkx6.1-expressing cells throughout zebrafish life and during beta cell regeneration.
    Ghaye AP; Bergemann D; Tarifeño-Saldivia E; Flasse LC; Von Berg V; Peers B; Voz ML; Manfroid I
    BMC Biol; 2015 Sep; 13():70. PubMed ID: 26329351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into Diabetes Cell Therapy.
    Lysy PA; Corritore E; Sokal EM
    Curr Diab Rep; 2016 May; 16(5):38. PubMed ID: 26983626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal Cell Reprogramming to Insulin-Producing Beta-Like Cells as a Potential Beta Cell Replacement Source for Chronic Pancreatitis.
    Jawahar AP; Narayanan S; Loganathan G; Pradeep J; Vitale GC; Jones CM; Hughes MG; Williams SK; Balamurugan AN
    Curr Stem Cell Res Ther; 2019; 14(1):65-74. PubMed ID: 30227823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells.
    Corritore E; Lee YS; Pasquale V; Liberati D; Hsu MJ; Lombard CA; Van Der Smissen P; Vetere A; Bonner-Weir S; Piemonti L; Sokal E; Lysy PA
    Stem Cells Transl Med; 2016 Nov; 5(11):1525-1537. PubMed ID: 27405779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic β-cell replacement: advances in protocols used for differentiation of pancreatic progenitors to β-like cells.
    Ghani MW; Ye L; Yi Z; Ghani H; Birmani MW; Nawab A; Cun LG; Bin L; Mei X
    Folia Histochem Cytobiol; 2019; 57(3):101-115. PubMed ID: 31396945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro differentiation of pancreatic beta-cells.
    Soria B
    Differentiation; 2001 Oct; 68(4-5):205-19. PubMed ID: 11776473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic progenitors: The shortest route to restore islet cell mass.
    Venkatesan V; Gopurappilly R; Goteti SK; Dorisetty RK; Bhonde RR
    Islets; 2011; 3(6):295-301. PubMed ID: 21934353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic β-cell regeneration: Facultative or dedicated progenitors?
    Afelik S; Rovira M
    Mol Cell Endocrinol; 2017 Apr; 445():85-94. PubMed ID: 27838399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular therapy of diabetes: focus on the latest developments].
    Lysy PA
    Med Sci (Paris); 2016 Apr; 32(4):401-7. PubMed ID: 27137698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells.
    Bonner-Weir S; Inada A; Yatoh S; Li WC; Aye T; Toschi E; Sharma A
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):353-6. PubMed ID: 18481956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of pancreatic beta-cells from stem cells.
    Noguchi H
    Curr Diabetes Rev; 2010 May; 6(3):184-90. PubMed ID: 20380628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell replacement and regeneration therapy for diabetes.
    Jun HS
    Korean Diabetes J; 2010 Apr; 34(2):77-83. PubMed ID: 20548838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes.
    Cito M; Pellegrini S; Piemonti L; Sordi V
    Endocr Connect; 2018 Mar; 7(3):R114-R125. PubMed ID: 29555660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.